We are live on ! Find out more
ROTUOC

Regents of the University of California Portfolio holdings

AUM $4.36B
1-Year Est. Return 33.89%
This Fund
S&P 500
This Quarter Est. Return
-1.1%
1 Year Est. Return
+33.89%
3 Year Est. Return
+86.09%
5 Year Est. Return
+63.96%
10 Year Est. Return
+870.04%
AUM
$719M
AUM Growth
+$6.6M
Cap. Flow
+$25.2M
Cap. Flow %
3.5%
Top 10 Hldgs %
97.86%
Holding
35
New
4
Increased
Reduced
4
Closed
6

Sector Composition

Rank Sector Weight
1 Financials 72.29%
2 Healthcare 10.88%
3 Consumer Staples 1.14%
4 Industrials 0.6%
5 Materials 0.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OBDC icon
1
Blue Owl Capital
OBDC
$5.84B
$515M 71.59%
42,690,843
-92,501
-0.2% -$1.13M
HYG icon
2
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
$98.9M 13.76%
+1,179,000
New +$99.2M
RAPT
3
DELISTED
RAPT Therapeutics
RAPT
$44.5M 6.18%
172,588
-23,942
-12% -$5.31M
CNST
4
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$25.1M 3.49%
1,237,406
EL icon
5
Estee Lauder
EL
$31.7B
$7.29M 1.01%
33,400
BE icon
6
Bloom Energy
BE
$71B
$3.15M 0.44%
+175,354
New +$2.62M
APD icon
7
Air Products & Chemicals
APD
$68B
$3.04M 0.42%
10,200
ORTX
8
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$2.55M 0.35%
62,023
-23,097
-27% -$1.19M
NTLA icon
9
Intellia Therapeutics
NTLA
$1.67B
$2.21M 0.31%
111,440
SPGI icon
10
S&P Global
SPGI
$122B
$2.16M 0.3%
6,000
MDY icon
11
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.2B
$1.9M 0.26%
5,600
MRK icon
12
Merck
MRK
$333B
$1.79M 0.25%
22,637
BRK.B icon
13
Berkshire Hathaway Class B
BRK.B
$1.09T
$1.71M 0.24%
8,043
XOM icon
14
ExxonMobil
XOM
$656B
$1.15M 0.16%
33,600
VZ icon
15
Verizon
VZ
$198B
$1.05M 0.15%
17,735
PFE icon
16
Pfizer
PFE
$153B
$1.01M 0.14%
29,138
TXN icon
17
Texas Instruments
TXN
$253B
$928K 0.13%
6,500
KO icon
18
Coca-Cola
KO
$377B
$889K 0.12%
18,000
GBT
19
DELISTED
Global Blood Therapeutics, Inc.
GBT
$768K 0.11%
13,928
DIS icon
20
Walt Disney
DIS
$179B
$744K 0.1%
6,000
HON icon
21
Honeywell
HON
$73.9B
$695K 0.1%
4,481
T icon
22
AT&T
T
$167B
$618K 0.09%
28,715
MRSH
23
Marsh
MRSH
$89.4B
$596K 0.08%
5,200
WFC icon
24
Wells Fargo
WFC
$266B
$426K 0.06%
18,106
ARVN icon
25
Arvinas
ARVN
$584M
$338K 0.05%
+14,333
New +$415K

Similar funds

Regents of the University of California's Q3 2020 Portfolio in Review

As of Q3 2020, Regents of the University of California held 35 positions worth $719M, up 0.93% from $713M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

Regents of the University of California deployed $25.2M of net new capital in Q3 2020, opening 4 new positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 1,179,000 shares worth $98.9M.

By sector, the portfolio is most concentrated in Financials at 72% of assets, down from 75% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was RAPT Therapeutics, an estimated $5.31M trimmed.

  • Regents of the University of California's largest Q3 2020 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 1,179,000 shares worth $98.9M.
  • Regents of the University of California's biggest Q3 2020 reduction was RAPT Therapeutics, cutting an estimated $5.31M.
  • Regents of the University of California fully exited Allogene Therapeutics in Q3 2020, selling an estimated $54.8M.
  • Regents of the University of California's ten largest holdings make up 98% of its $719M portfolio in Q3 2020.
  • Regents of the University of California opened 4 new positions and closed 6 in Q3 2020.
  • Regents of the University of California's portfolio value rose 0.93% quarter-over-quarter to $719M.

Based on Regents of the University of California's 13F filing for Q3 2020, filed 21 Oct 2020.